Skip to content

The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris

The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00737958
Enrollment
19
Registered
2008-08-20
Start date
2008-08-31
Completion date
2008-12-31
Last updated
2010-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina Pectoris, Coronary Heart Disease

Keywords

Angina pectoris, Air pollution, Diesel exhaust, Myocardial ischaemia, Exercise capacity

Brief summary

The purpose of this study is to determine whether exposure to diesel exhaust (air pollution) has a functional impact on patients with stable angina pectoris.

Detailed description

Air pollution is a major cause of cardiovascular morbidity and mortality. The mechanism and components of air pollution responsible for these cardiovascular effects are unknown but small combustion-derived particles are suspected to be the major cause. Using a unique exposure system in Umeå Sweden, we have demonstrated that healthy volunteers who inhale dilute diesel exhaust develop an impairment of two important, highly relevant and complementary aspects of vascular function: the regulation of vascular tone and endogenous fibrinolysis. We have recently extended these findings and have shown that brief exposure to dilute diesel exhaust promotes myocardial ischemia and inhibits endogenous fibrinolytic capacity in patients with stable asymptomatic coronary heart disease. We now wish to extend these findings to patients with chronic stable angina pectoris. In particular, we wish to determine the functional impact of diesel exhaust inhalation as well as describe the time course and minimum exposure that can induce these detrimental effects.

Interventions

None listed

Sponsors

University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Documented coronary heart disease * Symptoms of stable angina pectoris

Exclusion criteria

* History of arrhythmia * Severe 3 vessel coronary artery disease or left main stem stenosis that has not been revascularised * Resting conduction abnormality * Digoxin therapy * Uncontrolled hypertension * Renal or hepatic failure * Patients with unstable disease (ACS or unstable symptoms within 3 months) * Asthma * Intercurrent illness

Design outcomes

Primary

MeasureTime frame
Myocardial ischaemia - measured as time to 1mm ST segment depression on the ECG during standard BRUCE exercise stress testing.Immediately after exposure

Secondary

MeasureTime frame
Total ischaemic burden - assessed using 24 hour Holter ambulatory ECG monitoring24hrs after exposure
Total exercise capacity - assessed by maximal work done during exercise stress testImmediately after exposure
Biochemical evidence of myocardial ischaemia - plasma highly sensitive troponins, ischaemically modified albumin, fatty acid binding proteinBefore, after and at 24 hours after exposure

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026